Supporting these findings, a previous study reveals that systemic administration of CSF1 in another mouse model of ALS (SOD1G37R mouse), which leads to over-activation of peripheral CSF1R, accelerated disease progression but not MN death, highlighting the importance of peripheral CSF1R in ALS pathology18. This evidence concerns the gene CSF1 and amyotrophic lateral sclerosis.